Case-Based Roundtable Meetings Spotlight
Case-Based Roundtable Meetings Spotlight: December 2, 2022
Case-Based Roundtable Meetings Spotlight: December 1, 2022
Case-Based Roundtable Meetings Spotlight: November 1, 2022
Case-Based Roundtable Meetings Spotlight: November 2, 2022
October 2, 2022
October 1 2022
Case-Based Roundtable Meetings Spotlight: September 2022
Case-Based Roundtable Meetings Spotlight: August 2022
Volume: 5
Issue: 11
Case-Based Roundtable Meetings Spotlight: July 2, 2022
Case-Based Roundtable Meetings Spotlight: July 1, 2022
Case-Based Roundtable Meetings Spotlight: June 2022
Case-Based Roundtable Meetings Spotlight: May 2022
Case-Based Roundtable Meetings Spotlight: April 2 2022
Case-Based Roundtable Meetings Spotlight: April 1 2022
Case-Based Roundtable Meetings Spotlight: March 2022
Case-Based Roundtable Meetings Spotlight: February 1, 2022
Case-Based Roundtable Meetings Spotlight: February 2, 2022
Case-Based Roundtable Meetings Spotlight: January 1, 2022
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5